Met and HGF inhibition in triple-negative breast cancer cell lines

被引：0
|
作者：
Gaule, Patricia Brid
Collins, Denis
Walsh, Naomi
Duffy, Michael J.
Crown, John
O'Donovan, Norma
机构：
[1] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Clin Res Ctr, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[4] Dublin City Univ, Dublin 9, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
    Hastak, Kedar
    Alli, Elizabeth
    Ford, James M.
    CANCER RESEARCH, 2010, 70 (20) : 7970 - 7980
  • [42] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines
    Ibrahim, Toni
    Liverani, Chiara
    Mercatali, Laura
    Sacanna, Emanuele
    Zanoni, Michele
    Fabbri, Francesco
    Zoli, Wainer
    Amadori, Dino
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (04) : 1263 - 1270
  • [43] Effect of afatinib alone and in combination with dasatinib in triple-negative breast cancer cell lines.
    Ibrahim, Mohamed F. K.
    Canonici, Alexandra
    Collins, Denis
    Crown, John
    O'Donovan, Norma
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines
    Lavender, Nicole A.
    Chow, Donald
    Yin, Holly
    Berens, Michael E.
    Carpten, John D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [45] Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple-Negative Breast Cancer Cell Lines
    Wong, Fu Hou
    Palanirajan, Vijayaraj Kumar
    Ng, Edmond Siah Chye
    Tan, Chung Keat
    Tan, Eugenie Sin Sing
    Amini, Farahnaz
    PHARMACEUTICALS, 2022, 15 (09)
  • [46] Classification of molecular subtypes of triple-negative breast cancer cell lines using two models
    Fernandez, Jose Rodrigo Espinosa
    Eckhardt, Bedrich L.
    Lee, Jangsoon
    Seitz, Robert S.
    Hout, David R.
    Ring, Brian Z.
    Lim, Bora
    Ueno, Naoto T.
    CANCER RESEARCH, 2018, 78 (04)
  • [47] Vorinostat modulates the expression of the progesterone receptor in subtypes of triple-negative breast cancer cell lines
    Lyn-Cook, Beverly
    NouriEmamzadeh, Fatemeh
    Word, Beverly
    Moore, Rhonda
    Miranda-Carboni, Gustav
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 131 - 131
  • [48] Inhibition of BCL2 and XPO1 demonstrates synergistic effects in triple-negative breast cancer cell lines
    Jackson, Marilyn Marie
    Smoots, Stephen G.
    Dominguez, Adrian T.
    Dus, Evan
    Bagby, Stacey
    Binns, Cameron
    Pitts, Todd M.
    Diamond, Jennifer R.
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines
    Lavender, Nicole A.
    Chow, Donald
    Yin, Holly
    Carpten, John
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
12345